osimertinibnivolumabdurvalumab
…minantly stereotactic radiosurgery (SRS)) followed by continued osimertinib, with encouraging PFS/OS and acceptable toxicity. By contrast, …
3articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: lazertinib ×
lazertinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning lazertinib
3 articles · page 1 of 1osimertinibcrizotinibsotorasibatezolizumabdurvalumablorlatinibosimertinib-treated
…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…
osimertiniblazertinibgefitinibAlmonertiniberlotinibNSCLCEmbaseWeb of Scienceplacebo
…s of cardiac adverse events. Among third generation inhibitors, osimertinib (2.53, 1.53 to 4.19; high certainty; 8.9%) and lazertinib (2.84…